Home › Alzheimer's Disease › Rhode Island
Alzheimer's Disease clinical trials in Rhode Island
8 studies for Alzheimer's Disease are looking for participants at sites in Rhode Island.
Cities in Rhode Island
Dominantly Inherited Alzheimer Network (DIAN)
- Butler Hospital, Providence
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT00869817A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Alzheimer's Disease and Memory Disorders Center at Rhode Island Hospital, Providence
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Butler Hospital, Providence
RecruitingPhase 3
Ages 50 to 90 · All sexes · Updated Sep 21, 2026 · NCT07177352Alzheimer's Tau Platform: Master Protocol
- Butler Hospital Memory and Aging Program, Providence
RecruitingPhase 2
Ages 50 to 80 · All sexes · Updated Sep 8, 2026 · NCT06957418A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Rhode Island Mood & Memory Research Institute, East Providence
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Aug 20, 2026 · NCT06976216A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Butler Hospital, Providence
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Butler Hospital, Providence
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT05552157Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- K2 Medical Research, East Providence
RecruitingObservational studyHealthy volunteers welcome
Ages 60 to 90 · All sexes · Updated Apr 15, 2026 · NCT06584357From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.